Characteristics of Turkish colorectal cancer patients and bevacizumab preference.

Basit Öğe Kaydı
dc.authorid0000-0001-8825-4918
dc.authorid0000-0002-9584-6134
dc.authorid0000-0002-2756-8646
dc.contributor.authorCicin, Irfan
dc.contributor.authorGümüş, Mahmut
dc.contributor.authorUncu, Dogan
dc.contributor.authorOzkan, Metin
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorElkiran, Tamer E.
dc.contributor.authorIsikdogan, Abdurrahman
dc.date.accessioned2025-05-10T19:34:29Z
dc.date.issued2017
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET -- JUN 02-07, 2017 -- Chicago, IL
dc.description.abstract[No abstract available]
dc.description.sponsorshipAmer Soc Clin Oncol
dc.identifier.doi10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1200/JCO.2017.35.15_suppl.e15055
dc.identifier.urihttps://hdl.handle.net/20.500.14730/8539
dc.identifier.volume35
dc.identifier.wosWOS:000411895707157
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherAmer Soc Clinical Oncology
dc.relation.ispartofJournal of Clinical Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.titleCharacteristics of Turkish colorectal cancer patients and bevacizumab preference.
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu